These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22394334)

  • 21. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene.
    Hatch E; Sconce EA; Daly AK; Kamali F
    J Thromb Haemost; 2006 May; 4(5):1158-9. PubMed ID: 16689780
    [No Abstract]   [Full Text] [Related]  

  • 23. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study.
    Teichert M; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; De Smet PA; Witteman JC; Stricker BH
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):771-6. PubMed ID: 18218987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c.-1639G>A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy.
    Kovac MK; Maslac AR; Rakicevic LB; Radojkovic DP
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):558-63. PubMed ID: 20581661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.
    Namazi S; Azarpira N; Hendijani F; Khorshid MB; Vessal G; Mehdipour AR
    Clin Ther; 2010 Jun; 32(6):1050-60. PubMed ID: 20637959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
    McGimpsey SJ; Woodside JV; Bamford L; Gilchrist SE; Graydon R; McKeeman GC; Young IS; Hughes AE; Patterson CC; O'Reilly D; McGibbon D; Chakravarthy U
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4712-6. PubMed ID: 16303969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension.
    Turgut Cosan D; Yazıcı HU; Colak E; Soyocak A; Degirmenci I; Kurt H; Birdane A; Colak E; Gunes HV
    Genet Test Mol Biomarkers; 2017 May; 21(5):292-297. PubMed ID: 28281786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.
    Huang SW; Li Q; Zhu SY; Li L; Xiong F; Jia YK; Xu XM
    Clin Chem Lab Med; 2009; 47(1):26-31. PubMed ID: 19117406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
    Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
    Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
    Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
    Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.
    Quteineh L; Verstuyft C; Descot C; Dubert L; Robert A; Jaillon P; Becquemont L
    Thromb Haemost; 2005 Sep; 94(3):690-1. PubMed ID: 16268497
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of five platelet membrane glycoprotein polymorphisms in branch retinal vein occlusion.
    Salomon O; Moisseiev J; Vilganski T; Dardik R; Kurtz S; Shpringer E; Steinberg DM; Rosenberg N
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):485-8. PubMed ID: 16905953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association between vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) and the variability of warfarin dose requirement in a Japanese patient population.
    Yin T; Hanada H; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Tomoike H; Miyata T
    Thromb Res; 2008; 122(2):179-84. PubMed ID: 17996924
    [No Abstract]   [Full Text] [Related]  

  • 34. [Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Konovalova NV; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(6):59-65. PubMed ID: 21786578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms associated with the prevalence of retinal vein occlusion in a Greek population.
    Christodoulou A; Bagli E; Gazouli M; Moschos MM; Kitsos G
    Int Ophthalmol; 2019 Nov; 39(11):2637-2648. PubMed ID: 31065901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status.
    Crosier MD; Peter I; Booth SL; Bennett G; Dawson-Hughes B; Ordovas JM
    J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):112-9. PubMed ID: 19436136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants.
    Scibona P; Redal MA; Garfi LG; Arbelbide J; Argibay PF; Belloso WH
    Genet Mol Res; 2012 Jan; 11(1):70-6. PubMed ID: 22290467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of paraoxonase 1 L55M and Q192R single-nucleotide polymorphisms with age-related macular degeneration.
    Söğüt E; Ortak H; Aydoğan L; Benlı I
    Retina; 2013 Oct; 33(9):1836-42. PubMed ID: 23538572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
    Loriot MA; Beaune P
    Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of CYP2C9 and vitamin k oxide reductase complex (VKORC)1 polymorphisms on time to determine the warfarin maintenance dose.
    Aomori T; Obayashi K; Fujita Y; Araki T; Nakamura K; Nakamura T; Kurabayashi M; Yamamoto K
    Pharmazie; 2011 Mar; 66(3):222-5. PubMed ID: 21553655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.